PATH malaria

Donate to PATH's emergency appeal Because of the US cuts to foreign aid, PATH faces a critical funding gap that threatens 30% of our high-stakes health programs. Help us continue this lifesaving work—from vaccinating people against d...

On #WorldMalariaDay, we reflect on the progress achieved and reaffirm our commitment to a malaria-free future. Sustained investment in prevention, control, and eradication efforts is crucial. We are at a pivotal moment 🌍 Help support our lifesaving efforts give.path.org/campaign/665...

Combining #malaria interventions like chemoprevention, bed nets and vaccines can be highly effective, and as researchers argue in a report published in the Malaria Journal, implementation context is paramount. Read more: bit.ly/4cpc3AP

On a light red background, text reads: "How advocacy can accelerate health progress for mothers and children," alongside a megaphone icon and the PATH logo.

Accelerating progress for maternal & newborn health could save over 7 million lives by the end of this decade.

📢 This #WorldHealthDay, learn how advocates & decision-makers can drive action to help moms and children survive + thrive: bit.ly/4couuWm

#HopefulFutures @who.int

This #WorldHealthDay, we highlight our GiveWell Perennial Malaria Chemoprevention project that has helped more than 43,000 children in the DRC start their #healthybeginning by delivering antimalarial drugs to infants and children in their first 2 years of life.

The fight against malaria needs the energy and innovation of young leaders. With the right support and resources, the youth can drive action and mobilize funding to end malaria for good. It's our future, let's protect it. #PowerUpHealth
@pathmalaria.bsky.social @malariaconsortium.bsky.social

Smiling girls stand in a line in front of a building, wearing school uniforms. A text overlay reads: "Gavi needs at least US$ 9 billion for 2026-2030 to vaccinate over 500 million children and save at least 8 million lives. #ForOurFuture"

Everyone has a right to lifesaving vaccines, no matter where they live. At PATH, we’re proud to work with @gavi.org to give hundreds of millions of children a fair chance at a healthy life.

But millions more still miss out. It’s time to fully fund Gavi ➡️ bit.ly/3KQTvMQ

#VaccinesWork #ForOurFuture

Preventing typhoid with vaccines in Burkina Faso Burkina Faso introduced typhoid conjugate vaccines (TCVs), becoming the first in Francophone Africa to include TCVs in the routine childhood immunization schedule.

No child should miss out on protection from a vaccine-preventable disease.

Learn more about Burkina Faso’s efforts to end typhoid: www.path.org/our-impact/a...

#GlobalHealth #VaccinesWork

🎉It's #WorldNTDDay! 1.5 billion people remain affected by Neglected Tropical Diseases. We are proud to join the collective movement to #UniteActEliminate and #EndNTDs!

Health workers examining training documents for the STANDARD G6PD test, an accessible point-of-care diagnostic that enables safe and effective malaria treatment. The test is now prequalified by the World Health Organization.

🌟 The first point-of-care diagnostic test for G6PD deficiency has achieved @who.int prequalification 🌟

Developed by SD Biosensor & PATH, the STANDARD G6PD Test is a critically needed tool. Congrats to the many partners who contributed to this milestone in the fight to #EndMalaria!

bit.ly/3PKB0fj

As we face multiple health crises — including #mpox, #cholera, and #AMR — a strong & effective @who.int is more critical than ever. We urge the Trump Administration to reconsider its position on US withdrawal from WHO.

Read our full statement: bit.ly/3EhfXys

#VaccinesWork ✨

@gavi.org reports on Cameroon’s #malaria vaccine rollout, one year into the campaign ⏬

@pathmalaria.bsky.social
is hiring! Are you an early-career professional interested in building your skills in data analysis through a mentorship program while providing support to National Malaria Programs in either DRC, CAR, or Nigeria? Check us out!

path.wd1.myworkdayjobs.com/en-US/Extern...

As always, the #TropMed24 conference was an excellent opportunity to reconnect with colleagues, partners, and experts from around the world to discuss the progress we’re making to #EndMalaria and NTDs and plan the exciting work ahead. (11/11)

In #Senegal, the Enhancing Global Health Security project made strides toward improving the quality of #meningitis data by integrating laboratory results with surveillance data. In 2024, PATH trained 100 health workers on a newly developed @dhis_2 E-Tracker module. (10/11)

MACEPA launched a data analytics fellowship program to support the growing need for Africa-based quantitative technical expertise to support national #malaria programs. PATH program manager Femi Adepoju led the virtual kick-off meeting on October 21, 2024 (pictured). (9/11)

To accelerate #malaria elimination in #Nigeria, the MOH partnered with PATH for assistance in developing a pragmatic, costed operational plan. In August, PATH co-hosted a meeting to frame this plan with key stakeholders and Director of Public Health Dr. Chukwuma Anyaike. (8/11)

In 2024, PATH celebrated 20 years of malaria partnership in #Zambia. Since 2004, PATH has led several large malaria projects supporting the NMEC, including MACEPA and PMI PAMO Plus. MACEPA has helped build a network of 25,000 CHWs across Zambia - like Margret Chalo below. (7/11)

Partnering with the Central African Republic (CAR) Malaria Control Service (SLP; building pictured), MACEPA conducted a capacity assessment of the SLP in 2024 and is launching an in-depth malaria surveillance assessment - PATH's first-ever partnership with CAR. (6/11)

The late Dr. Carlos “Kent” Campbell passed away in February 2024. The founder of PATH MACEPA, he is remembered as a visionary leader in the fight against malaria. In November, our team celebrated his life with a tribute symposium at @ASTMH. Learn more: www.path.org/our-impact/a... (5/11)

A mother holds medicine for seasonal malaria chemoprevention (SMC) for her child. PMI REACH Malaria, led by @PATHtweets, supported Togo's first-ever SMC campaign in the Plateaux region, marking PMI’s first activity in Togo and reaching 113,600 children. (4/11)

As part of the ATSB project and in partnership with the Zambia National Elimination Centre, PATH’s entomological surveillance team collected #malaria-transmitting mosquitoes using light traps and sent them to the PATH Kaoma entomology lab for analysis. (3/11)

Throughout 2024, PATH concluded and published results from the first large-scale randomized controlled trial of the Attractive Targeted Sugar Bait (ATSB), a new tool designed to attract and kill mosquitoes. Here, Mwansa Mwenya installs an ATSB as part of the trial in Kaoma, Zambia. (2/11)

As another year ends, @PATHMalaria reflects on all we've accomplished with our partners. We remain committed to the audacious goal to #EndMalaria for all, even amidst challenges like #AMDR and climate change. In this 🧵, we share photos illustrating key moments in 2024. (1/11)

@who.int has released their #WorldMalariaReport! Although major progress has been made, we must continue to commit ourselves to an equitable and aligned fight against #malaria. bit.ly/3VzeTvE

New study from Namibia shows that malaria rapid diagnostic tests (RDTs) can stay positive for weeks after treatment. Standard RDTs had a median positivity of 42 days, while new ultra-sensitive RDTs remined positive for 67 days. Implications for surveillance & elimination. 🦟🔬 tinyurl.com/ymfrbwjz

Could we get added to your start pack please Madhu!

First single-dose medicine for P. vivax malaria prequalified by WHO and included in WHO Guidelines | Medicines for Malaria Venture The World Health Organization has awarded prequalification to tafenoquine, the first single-dose medicine for the prevention of relapse of Plasmodium vivax malaria.

Exciting news: @who.int has prequalified tafenoquine, a single-dose treatment for relapsing P. vivax malaria, and added it to their latest #malaria guidelines. Check it out 👇https://www.mmv.org/newsroom/news-resources-search/first-single-dose-medicine-p-vivax-malaria-prequalified-who-and

Fresh from ASTMH, PATH malaria team are excited to get started on Bluesky! Who's good to follow? Anyone read any good papers recently?